Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kerra
- Development stage
- Unknown
- Lead developer
- Quthero
- Modality
- Peptides
- Administration
- Topical
01
Overview
Kerra is a post-aesthetic recovery product developed by Quthero, designed to accelerate skin healing and reduce downtime following dermatological procedures such as laser resurfacing, chemical peels, and microneedling. The product is formulated using Quthero's proprietary 'Q-peptide' technology, which features the synthetic peptide sequence QHREDGS. This peptide is derived from the fibrinogen-like domain of angiopoietin-1 and acts as a biomimetic ligand for integrins, particularly alpha-v beta-3 and alpha-5 beta-1. By activating these receptors, Kerra promotes cell survival, adhesion, and migration, thereby enhancing the natural regenerative processes of the skin. Clinical data published in the Journal of Drugs in Dermatology supports its efficacy in improving healing outcomes in a multi-site, double-blind study.
- Brand names
- Kerra
- Other names
- Q-peptideQHREDGS
02
Targets
αVβ3 (Integrin αVβ3)ITGA5:ITGB1 (Integrin α5β1)
Beyond the preview
Go deeper on Kerra.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kerra.